| 1 |
31920463 | Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells. | 2020 |
1 |
| 2 |
29942081 | Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer. | 2018 Aug |
1 |
| 3 |
30292139 | A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma. | 2018 Dec 7 |
3 |
| 4 |
28386317 | Alisertib induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells. | 2017 |
1 |
| 5 |
27121204 | AURKA induces EMT by regulating histone modification through Wnt/β-catenin and PI3K/Akt signaling pathway in gastric cancer. | 2016 May 31 |
2 |
| 6 |
27177156 | Alisertib induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells. | 2016 Jul |
1 |
| 7 |
25632225 | Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells. | 2015 |
1 |
| 8 |
25792811 | Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. | 2015 |
2 |
| 9 |
25834401 | The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. | 2015 |
2 |